4
Changes in Ownership
Alaunos Therapeutics, Inc. Filed Acc 0000950170-23-046504
Chief Executive Officer sold 68,014 shares at $0.14 ($9,542)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Boyle Kevin S. Sr. Chief Executive Officer | 2023-09-01 | Sale 10b5-1 | −68,014 | $0.14 | $9,542 | 798,236 | D |
| Open-market sales · 68,014 sh · avg $0.14 · $9,542 | |||||||
Loading xslF345X05/ownership.xml…